SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-19-022809
Filing Date
2019-11-14
Accepted
2019-11-14 09:25:48
Documents
54
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q relv20190930_10q.htm 10-Q 1263875
2 EXHIBIT 31.1 ex_164076.htm EX-31.1 11895
3 EXHIBIT 31.2 ex_164078.htm EX-31.2 11862
4 EXHIBIT 32 ex_164079.htm EX-32 6535
  Complete submission text file 0001437749-19-022809.txt   4930049

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT relv-20190930.xml EX-101.INS 921331
6 XBRL TAXONOMY EXTENSION SCHEMA relv-20190930.xsd EX-101.SCH 44554
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE relv-20190930_cal.xml EX-101.CAL 52573
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE relv-20190930_def.xml EX-101.DEF 316243
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE relv-20190930_lab.xml EX-101.LAB 297170
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE relv-20190930_pre.xml EX-101.PRE 337216
Mailing Address 136 CHESTERFIELD INDUSTRIAL BLVD P O BOX 405 CHESTERFIELD MO 63006-0405
Business Address 136 CHESTERFIELD INDUSTRIAL BLVD P O BOX 405 CHESTERFIELD MO 63006-0405 636-537-9715
RELIV INTERNATIONAL INC (Filer) CIK: 0000768710 (see all company filings)

IRS No.: 371172197 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19932 | Film No.: 191216857
SIC: 2834 Pharmaceutical Preparations